NRXP · Categories · Form 4

NRXP - SEC Form 4 insider transactions

NRX Pharmaceuticals Inc. (NRXP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NRXP

• 112d
  SEC Form 4 filed by Chief Operating Officer Casper Joseph Michael

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 273d
  SEC Form 4 filed by Chairman and Chief Scientist Javitt Jonathan C

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 273d
  SEC Form 4 filed by Director Mcbride Dennis

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 273d
  SEC Form 4 filed by Director Hurvitz Chaim

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 273d
  SEC Form 4 filed by Director Flynn Patrick John

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 483d
  SEC Form 4 filed by Chief Financial Officer Abrams Michael S

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1003d
  SEC Form 4: Gorovitz Aaron bought $11,196 worth of shares (35,000 units at $0.32)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1003d
  SEC Form 4: Hurvitz Chaim bought $20,125 worth of shares (70,000 units at $0.29), increasing direct ownership by 14% to 570,000 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1022d
  SEC Form 4: Javitt Jonathan C bought $64,400 worth of shares (200,000 units at $0.32), increasing direct ownership by 137% to 346,332 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1269d
  SEC Form 4: Willard Stephen H bought $58,500 worth of shares (50,000 units at $1.17)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1269d
  SEC Form 4: Van Voorhees Seth bought $33,000 worth of shares (30,000 units at $1.10), increasing direct ownership by 184% to 46,337 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1269d
  SEC Form 4: Van Voorhees Seth bought $18,215 worth of shares (16,337 units at $1.11) (Amendment)

  4/A - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1278d
  SEC Form 4: Javitt Jonathan C sold $400,000 worth of shares (400,000 units at $1.00)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1286d
  SEC Form 4: Javitt Daniel C. sold $33,352 worth of shares (22,171 units at $1.50) as part of a pre-agreed trading plan

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1289d
  SEC Form 4: Flynn Patrick John bought $14,662 worth of shares (11,750 units at $1.25)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1290d
  SEC Form 4: Van Voorhees Seth bought $18,215 worth of shares (16,337 units at $1.11)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1295d
  SEC Form 4: Hurvitz Chaim bought $514,905 worth of shares (500,000 units at $1.03) (Amendment)

  4/A - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1295d
  SEC Form 4 filed by Gorovitz Aaron

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1295d
  SEC Form 4 filed by Glied Sharon

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1295d
  SEC Form 4 filed by Flynn Patrick John

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1296d
  SEC Form 4: Hurvitz Chaim bought $514,905 worth of shares (500,000 units at $1.03)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1299d
  SEC Form 4: Javitt Daniel C. sold $171,138 worth of shares (166,737 units at $1.03) as part of a pre-agreed trading plan

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1302d
  SEC Form 4: Javitt Daniel C. sold $49,510 worth of shares (49,200 units at $1.01) as part of a pre-agreed trading plan

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1407d
  SEC Form 4: Javitt Daniel C. sold $791,433 worth of shares (784,063 units at $1.01)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1436d
  SEC Form 4: Javitt Daniel C. gifted 2,000,000 shares

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1463d
  SEC Form 4: Javitt Daniel C. sold $303,910 worth of shares (445,712 units at $0.68)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1469d
  SEC Form 4: Javitt Jonathan C bought $58,000 worth of shares (100,000 units at $0.58), increasing direct ownership by 216% to 146,332 units (Amendment)

  4/A - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1469d
  SEC Form 4: Javitt Jonathan C bought $5,800,000 worth of shares (100,000 units at $58.00), increasing direct ownership by 216% to 146,332 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1553d
  SEC Form 4 filed by Besthof Robert

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1681d
  SEC Form 4: Mcmaster Herbert Raymond exercised 18,300 shares at a strike of $2.22

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1681d
  SEC Form 4: Javitt Daniel C. gifted 869,188 shares

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1681d
  SEC Form 4: Daigneault Alessandra exercised 58,979 shares at a strike of $3.07 and sold $442,004 worth of shares (33,715 units at $13.11), increasing direct ownership by 400% to 31,584 units

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1681d
  SEC Form 4: Besthof Robert exercised 63,710 shares at a strike of $0.20 and sold $470,400 worth of shares (40,000 units at $11.76)

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Troy Daniel was granted 43,093 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Javitt Jonathan C was granted 14,817,329 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Javitt Daniel C. was granted 13,971,864 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Hurvitz Chaim was granted 1,644,793 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Gorovitz Aaron was granted 41,686 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Glied Sharon was granted 13,168 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4 filed by Fricker William

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Flynn Patrick John was granted 432,750 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4: Daigneault Alessandra was granted 6,320 units of Common Stock

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)
• 1825d
  SEC Form 4 filed by Besthof Robert

  4 - NRX Pharmaceuticals, Inc. (0001719406) (Issuer)

Other NRXP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends